Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Sify Technologies Limited

20.1% sales growth and 6.38% return on equity

Sify Technologies Limited provides integrated ICT solutions and services in India and internationally.

Sify Technologies Limited’s sales growth this year is expected to be 11% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 1.6%, now sitting on N/A for the twelve trailing months.

Sify Technologies Limited’s sales growth is a negative 0% for the current quarter and 20.1% for the next. The company’s growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.38%.

Volatility

Sify Technologies Limited’s last day, last week, and last month’s average volatility was 3.92%, 4.62%, and 1.78%, respectively.

Sify Technologies Limited’s last day, last week, and last month’s high and low average amplitude percentage was 6.67%, 8.05%, and 5.65%, respectively.

Sify Technologies Limited’s Stock Yearly Top and Bottom Value

Sify Technologies Limited’s stock is valued at $2.64 at 16:22 EST, way under its 52-week high of $3.69 and way higher than its 52-week low of $0.56.

Sify Technologies Limited’s Moving Average

Sify Technologies Limited’s worth is way above its 50-day moving average of $1.23 and way above its 200-day moving average of $1.12.

2. New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share

23% sales growth and 10.41% return on equity

New Oriental Education & Technology Group Inc. provides private educational services under the New Oriental brand in the People's Republic of China.

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s sales growth this year is anticipated to be 16.8% and 32.9% for next year.

Year-on-year quarterly revenue growth declined by 8%, now sitting on 3.49B for the twelve trailing months.

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s sales growth is a negative 0% for the ongoing quarter and 23% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 5.6% and 12.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.41%.

Volatility

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s last day, last week, and last month’s average volatility was a positive 1.32%, a negative 0.12%, and a positive 0.27%, respectively.

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s last day, last week, and last month’s high and low average amplitude percentage was 2.42%, 3.36%, and 3.86%, respectively.

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s Stock Yearly Top and Bottom Value

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s stock is valued at $175.09 at 16:22 EST, below its 52-week high of $187.43 and way higher than its 52-week low of $102.01.

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s Moving Average

New Oriental Education & Technology Group, Inc. Sponsored ADR representing 1 Ordinary Share’s worth is higher than its 50-day moving average of $169.06 and way above its 200-day moving average of $158.10.

3. ProLogis, Inc.

13.4% sales growth and 5.56% return on equity

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets.

ProLogis, Inc.’s sales growth this year is anticipated to be 34% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 17%, now sitting on 4.42B for the twelve trailing months.

ProLogis, Inc.’s sales growth for the next quarter is 13.4%. The company’s growth estimates for the ongoing quarter and the next is a negative 39% and negative -42.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.56%.

Volatility

ProLogis, Inc.’s last day, last week, and last month’s average volatility was a positive 1.34%, a negative 0.64%, and a negative 0.02%, respectively.

ProLogis, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.57%, 2.59%, and 2.11%, respectively.

ProLogis, Inc.’s Stock Yearly Top and Bottom Value

ProLogis, Inc.’s stock is valued at $96.60 at 16:22 EST, way below its 52-week high of $112.37 and way above its 52-week low of $59.82.

ProLogis, Inc.’s Moving Average

ProLogis, Inc.’s value is below its 50-day moving average of $97.97 and under its 200-day moving average of $100.05.

4. Hologic, Inc.

78.5% sales growth and 46.05% return on equity

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally.

Hologic, Inc.’s sales growth this year is anticipated to be 35.9% and a negative 16.5% for next year.

Year-on-year quarterly revenue growth grew by 55.5%, now sitting on 3.78B for the twelve trailing months.

Hologic, Inc.’s sales growth is a negative 0% for the present quarter and 78.5% for the next. The company’s growth estimates for the present quarter and the next is 250.8% and 252.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.05%.

Volatility

Hologic, Inc.’s last day, last week, and last month’s average volatility was 3.23%, 2.03%, and 0.49%, respectively.

Hologic, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.74%, 4.48%, and 3.51%, respectively.

Hologic, Inc.’s Stock Yearly Top and Bottom Value

Hologic, Inc.’s stock is valued at $80.49 at 16:22 EST, under its 52-week high of $81.80 and way higher than its 52-week low of $26.49.

Hologic, Inc.’s Moving Average

Hologic, Inc.’s worth is higher than its 50-day moving average of $73.27 and way higher than its 200-day moving average of $66.95.

5. Ichor Holdings

9.4% sales growth and 12.43% return on equity

Ichor Holdings, Ltd.

Ichor Holdings’s sales growth this year is expected to be 46.1% and 13.2% for next year.

Year-on-year quarterly revenue growth grew by 47.4%, now sitting on 858.63M for the twelve trailing months.

Ichor Holdings’s sales growth for the next quarter is 9.4%. The company’s growth estimates for the ongoing quarter and the next is 43.7% and 21.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.43%.

Volatility

Ichor Holdings’s last day, last week, and last month’s average volatility was a negative 1.00%, a positive 1.56%, and a positive 0.70%, respectively.

Ichor Holdings’s last day, last week, and last month’s high and low average amplitude percentage was 4.59%, 5.30%, and 4.30%, respectively.

Ichor Holdings’s Stock Yearly Top and Bottom Value

Ichor Holdings’s stock is valued at $40.95 at 16:22 EST, below its 52-week high of $41.17 and way higher than its 52-week low of $13.68.

Ichor Holdings’s Moving Average

Ichor Holdings’s worth is way above its 50-day moving average of $32.87 and way higher than its 200-day moving average of $27.85.

6. M/I Homes, Inc.

18.9% sales growth and 18.93% return on equity

M/I Homes, Inc., together with its subsidiaries, operates as a builder of single-family homes in Ohio, Indiana, Illinois, Michigan, Minnesota, North Carolina, Florida, and Texas, the United States.

M/I Homes, Inc.’s sales growth this year is anticipated to be 24.1% and 4.1% for next year.

Year-on-year quarterly revenue growth grew by 29.8%, now sitting on 2.88B for the twelve trailing months.

M/I Homes, Inc.’s sales growth for the next quarter is 18.9%. The company’s growth estimates for the current quarter and the next is 54.1% and 15.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.93%.

Volatility

M/I Homes, Inc.’s last day, last week, and last month’s average volatility was a negative 5.21%, a positive 0.02%, and a positive 0.04%, respectively.

M/I Homes, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 7.50%, 5.42%, and 4.07%, respectively.

M/I Homes, Inc.’s Stock Yearly Top and Bottom Value

M/I Homes, Inc.’s stock is valued at $44.34 at 16:22 EST, way under its 52-week high of $49.93 and way higher than its 52-week low of $9.62.

M/I Homes, Inc.’s Moving Average

M/I Homes, Inc.’s value is under its 50-day moving average of $45.21 and higher than its 200-day moving average of $42.94.

7. Molina Healthcare Inc

24.7% sales growth and 40.03% return on equity

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.

Molina Healthcare Inc’s sales growth this year is anticipated to be 16% and 17.3% for next year.

Year-on-year quarterly revenue growth grew by 16%, now sitting on 17.66B for the twelve trailing months.

Molina Healthcare Inc’s sales growth for the next quarter is 24.7%. The company’s growth estimates for the present quarter and the next is a negative 46.9% and 21.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.03%.

Volatility

Molina Healthcare Inc’s last day, last week, and last month’s average volatility was 0.43%, 2.76%, and 0.60%, respectively.

Molina Healthcare Inc’s last day, last week, and last month’s high and low average amplitude percentage was 3.35%, 4.40%, and 3.03%, respectively.

Molina Healthcare Inc’s Stock Yearly Top and Bottom Value

Molina Healthcare Inc’s stock is valued at $243.10 at 16:22 EST, below its 52-week high of $246.72 and way higher than its 52-week low of $102.85.

Molina Healthcare Inc’s Moving Average

Molina Healthcare Inc’s value is way above its 50-day moving average of $210.05 and way higher than its 200-day moving average of $194.64.

8. Agnico Eagle Mines Limited

49.4% sales growth and 12.43% return on equity

Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland.

Agnico Eagle Mines Limited’s sales growth this year is anticipated to be 26.4% and 30% for next year.

Year-on-year quarterly revenue growth grew by 43.6%, now sitting on 2.96B for the twelve trailing months.

Agnico Eagle Mines Limited’s sales growth for the next quarter is 49.4%. The company’s growth estimates for the present quarter and the next is 91.9% and 321.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.43%.

Volatility

Agnico Eagle Mines Limited’s last day, last week, and last month’s average volatility was a negative 1.97%, a negative 1.00%, and a negative 0.11%, respectively.

Agnico Eagle Mines Limited’s last day, last week, and last month’s high and low average amplitude percentage was 2.20%, 2.05%, and 2.86%, respectively.

Agnico Eagle Mines Limited’s Stock Yearly Top and Bottom Value

Agnico Eagle Mines Limited’s stock is valued at $68.65 at 16:22 EST, way below its 52-week high of $89.23 and way above its 52-week low of $31.00.

Agnico Eagle Mines Limited’s Moving Average

Agnico Eagle Mines Limited’s value is under its 50-day moving average of $71.05 and under its 200-day moving average of $75.46.

LEAVE A REPLY

Please enter your comment!
Please enter your name here